Patents & Licensing

Focusing on the future growth of Vivera’s various divisions, the Company has filed several patent applications for new medical devices, technologies, and pharmaceutical treatments utilizing the TABMELT platform.

Behind the development of each product are years of expertise, research, design, and development focused on bringing the best solutions to the market for patients and their providers.

Vivera has begun laying the groundwork for clinical research trials for a variety of indications, via the Investigational New Drug (IND) and/or New Drug Application (NDA) pathways, to gain FDA approval and globally commercialize its finished pharmaceutical products.

TABMELT BioSciences Patents

Cardiovascular

Jurisdiction Compound Patent Status
United States VVRA – TM 001 Filed

Central Nervous System

Jurisdiction Compound Patent Status
United States VVRA – TM 002 Published
United States VVRA – TM 003 Filed
United States VVRA – TM 004 Filed
United States VVRA – TM 005 Published
United States PTNR – TM 006 Filed
United States PTNR – TM 007 Filed

Childhood-Onset Fluency Disorder (Stuttering)

Jurisdiction Compound Patent Status
United States VVRA – TM 008 Published

Licensed TABMELT Patents

Jurisdiction Title Patent Status
Australia All Natural, Non-Toxic Sublingual Drug Delivery Systems Issued, 2016
Canada All Natural, Non-Toxic Sublingual Drug Delivery Systems Issued, 2018
Great Britain All Natural, Non-Toxic Sublingual Drug Delivery Systems Issued, 2018
Russia All Natural, Non-Toxic Sublingual Drug Delivery Systems Issued, 2021
Israel All Natural, Non-Toxic Sublingual Drug Delivery Systems Filed
Japan All Natural, Non-Toxic Sublingual Drug Delivery Systems Filed
Mexico All Natural, Non-Toxic Sublingual Drug Delivery Systems Filed
United States All Natural, Non-Toxic Sublingual Drug Delivery Systems Published

ZICOH Medical Technologies Patents

Jurisdiction Title Patent Status
United States Smart Inhaler Device With Automated Dose Delivery, Measurement, and Management Issued, 2021
United States Secure Smart Dosing System With Automated Delivery, Measurement, and Management Issued, 2021
United States Secure Smart Dosing System With Automated Delivery, Measurement, and Management for Pills Allowed
Australia Smart Inhaler Device With Automated Dose Delivery, Measurement, and Management Filed
Canada Smart Inhaler Device With Automated Dose Delivery, Measurement, and Management Filed
United Kingdom Smart Inhaler Device With Automated Dose Delivery, Measurement, and Management Filed
World Intellectual Property Organization Smart Inhaler Device With Automated Dose Delivery, Measurement, and Management Published
Australia Secure Smart Dosing System With Automated Delivery, Measurement, and Management Pending
Canada Secure Smart Dosing System With Automated Delivery, Measurement, and Management Filed
Israel Secure Smart Dosing System With Automated Delivery, Measurement, and Management Filed
United Kingdom Secure Smart Dosing System With Automated Delivery, Measurement, and Management Filed
World Intellectual Property Organization Secure Smart Dosing System With Automated Delivery, Measurement, and Management Published

Medical Technologies Patents

Jurisdiction Title Patent Status
United States Self-Contained, Portable, Sanitization Device and Telemedicine Station Allowed
United States Neurosciences Medical Device Software Filed
United States Self-Administered Infection Testing and Result Determination Published

Indication Schedule